Dr. Constantin Dasanu, MD, PhD

Dr. Dasanu practices at Christus Spohn Hospital - Corpus Christi in Kingsville, Texas.

Dr. Dasanu's NPI, 1922120708, was assigned on April 4, 2007. Dr. Dasanu graduated from Nicolae Testemitanu State University of Medicine and Pharmacy in 1991. Dr. Dasanu holds California license C129085.

Dr. Dasanu's primary practice is Christus Spohn Hospital - Corpus Christi, at 608 Elizabeth Ave, Kingsville, TX 78363 in Kleberg County. The practice phone is (361) 881-3000.

Dr. Dasanu's primary practice is Christus Spohn Hospital - Corpus Christi in Kingsville, Texas. Dr. Dasanu is also affiliated with CHRISTUS Spohn Hospital Corpus Christi - Shoreline. The medical group on file is CHRISTUS Trinity Clinic. Dmand AI also links Dr. Dasanu to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dasanu practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dasanu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dasanu is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Dasanu's licenses on file in 5 states: California, Texas, Connecticut, Washington and Idaho.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Dasanu treats.

CMS data shows 3,591 Medicare services from Dr. Dasanu across 8 procedure codes in 2024, for 1,095 Medicare patients. Medicare paid $320,000 for them.

CMS counts 1,095 Medicare patients who saw Dr. Dasanu in 2024. The largest group is 75 to 84, with 505 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dasanu's median patient age at 71, with 50% women.

In 2024, Dr. Dasanu wrote 1,201 Medicare Part D claims for 229 patients. 61% of them were for generic drugs. CMS names the drug for 956 of them, across 23 drugs with 11 or more claims each, at $5,097,597 in total drug cost. In 2023, CMS named 780 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Dasanu for performance year 2024, reported as part of a group. Dr. Dasanu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dasanu as offering telehealth.

Dmand AI links 277 papers to Dr. Dasanu, published from 2006 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Antineoplastic Agents, Lung Neoplasms and Melanoma. Dr. Dasanu has published most often in J Oncol Pharm Pract. Dr. Dasanu's most frequent co-authors are Steven C. Plaxe, MD, Andrew Samir Iskandar, MD and Ashif K. Jethava, MD.

Dmand AI links Dr. Dasanu to 12 clinical trials, 9 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Cystadenocarcinoma, Mucinous, Lymphoma, Follicular and Melanoma. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 26 general payments to Dr. Dasanu from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 59% of the total. AstraZeneca Pharmaceuticals LP paid the most, $350.

Dr. Dasanu graduated from Nicolae Testemitanu State University of Medicine and Pharmacy in 1991.

Dr. Dasanu is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.